We are live on
!
Find out more
GA
General Atlantic Portfolio holdings
AUM
$2.15B
1-Year Est. Return
35.02%
This Fund
S&P 500
This Quarter
Est. Return
+10.97%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$6.34B
AUM Growth
-$2.26B
(-26%)
Cap. Flow
-$2.41B
Cap. Flow
% of AUM
-38.05%
Top 10 Holdings %
Top 10 Hldgs %
86.83%
Holding
33
New
2
Increased
4
Reduced
2
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AKRO
Akero Therapeutics
AKRO
|
+$81.8M |
| 2 |
XP
XP
|
+$73M |
| 3 |
SLRN
ACELYRIN
SLRN
|
+$30.7M |
| 4 |
dLocal
DLO
|
+$28.6M |
| 5 |
Pharvaris
PHVS
|
+$19.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OSH
Oak Street Health, Inc.
OSH
|
+$2.37B |
| 2 |
Samsara
IOT
|
+$182M |
| 3 |
Duolingo
DUOL
|
+$83.6M |
| 4 |
CIH
China Index Holdings Limited American Depository Shares
CIH
|
+$9.54M |
| 5 |
LOGC
ContextLogic
LOGC
|
+$8 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 59.18% |
| 2 | Healthcare | 15.37% |
| 3 | Financials | 11.65% |
| 4 | Industrials | 5.72% |
| 5 | Consumer Staples | 4.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESMT
1
DELISTED
EngageSmart, Inc.
ESMT
| $1.72B | 27.16% |
90,271,540
| – | – |
|
|
2
dLocal
DLO
$4.28B
| $780M | 12.29% |
63,906,695
+2,160,680
| +3% | +$28.6M |
|
|
SQSP
3
DELISTED
Squarespace, Inc.
SQSP
| $705M | 11.12% |
22,361,073
| – | – |
|
|
4
XP
XP
$8.41B
| $695M | 10.95% |
29,617,733
+4,300,000
| +17% | +$73M |
|
|
HRT
5
DELISTED
HireRight Holdings Corporation
HRT
| $363M | 5.72% |
32,109,898
| – | – |
|
6
Alignment Healthcare
ALHC
$3.81B
| $351M | 5.53% |
60,993,323
| – | – |
|
7
Alkami Technology
ALKT
$1.96B
| $307M | 4.84% |
18,729,806
| – | – |
|
|
EWCZ
8
DELISTED
European Wax Center
EWCZ
| $244M | 3.85% |
13,110,492
| – | – |
|
9
Mobileye
MBLY
$2.03B
| $183M | 2.88% |
4,761,905
| – | – |
|
|
KRTX
10
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $158M | 2.48% |
726,958
+10,800
| +2% | +$2.31M |
|
11
Clear Secure
YOU
$5.68B
| $113M | 1.78% |
4,861,120
| – | – |
|
|
AKRO
12
DELISTED
Akero Therapeutics
AKRO
| $83.4M | 1.31% |
+1,785,714
| New | +$81.8M |
|
|
13
Duolingo
DUOL
$6.56B
| $83M | 1.31% |
580,642
-583,652
| -50% | -$83.6M |
|
|
14
Pharvaris
PHVS
$2.26B
| $66.7M | 1.05% |
4,406,252
+1,986,097
| +82% | +$19.2M |
|
15
Ginkgo Bioworks
DNA
$494M
| $60.1M | 0.95% |
807,997
| – | – |
|
|
CNTA
16
DELISTED
Centessa Pharmaceuticals
CNTA
| $59.9M | 0.94% |
9,681,818
| – | – |
|
17
Immunocore
IMCR
$1.68B
| $57M | 0.9% |
950,000
| – | – |
|
|
ARCE
18
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $49.8M | 0.79% |
4,103,366
| – | – |
|
19
HUTCHMED
HCM
$1.95B
| $48M | 0.76% |
4,000,000
| – | – |
|
20
Royalty Pharma
RPRX
$26.7B
| $46.1M | 0.73% |
1,500,000
| – | – |
|
21
Futu Holdings
FUTU
$14.3B
| $44.2M | 0.7% |
1,111,544
| – | – |
|
|
SLRN
22
DELISTED
ACELYRIN
SLRN
| $31.4M | 0.49% |
+1,500,000
| New | +$30.7M |
|
23
Riskified
RSKD
$728M
| $25.9M | 0.41% |
5,324,998
| – | – |
|
24
Opendoor
OPEN
$3.68B
| $25.4M | 0.4% |
6,532,236
| – | – |
|
25
Blend Labs
BLND
$436M
| $18.1M | 0.29% |
19,132,440
| – | – |
|
Similar funds
NAAA
MA
SC
IIP
CI
AAP
RFP
TAL
General Atlantic's Q2 2023 Portfolio in Review
As of Q2 2023, General Atlantic held 33 positions worth $6.34B, down 26% from $8.61B the previous quarter. Its ten largest holdings account for 87% of the portfolio.
General Atlantic withdrew a net $2.41B in Q2 2023, closing 3 positions and reducing 2 holdings. Its most notable exit was Oak Street Health, Inc., an estimated $2.37B position sold in full.
By sector, the portfolio is most concentrated in Technology at 59% of assets, up from 49% a quarter earlier, followed by Healthcare and Financials.
Against the trend, General Atlantic opened a new position in Akero Therapeutics worth $83.4M.
- General Atlantic's largest Q2 2023 buy was Akero Therapeutics: 1,785,714 shares worth $83.4M.
- General Atlantic added most to XP in Q2 2023, an estimated $73M increase.
- General Atlantic's biggest Q2 2023 reduction was Duolingo, cutting an estimated $83.6M.
- General Atlantic fully exited Oak Street Health, Inc. in Q2 2023, selling an estimated $2.37B.
- General Atlantic's ten largest holdings make up 87% of its $6.34B portfolio in Q2 2023.
- General Atlantic opened 2 new positions and closed 3 in Q2 2023.
- General Atlantic's portfolio value fell 26% quarter-over-quarter to $6.34B.
Based on General Atlantic's 13F filing for Q2 2023, filed 11 Aug 2023.